CTOs on the Move

Aaron Diamond AIDS Research Center

www.adarc.org

 
Aaron Diamond AIDS Research Center is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.adarc.org
  • 455 1st Ave
    New York, NY USA 10016
  • Phone: 212.448.5000

Executives

Name Title Contact Details

Similar Companies

San Antonio AIDS Foundation

San Antonio AIDS Foundation is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Faith Health Care

Faith Health Care is a licensed home health agency that provides exceptional quality home health care, multi-disease management, and transitional care services. They are Medicare and Medicaid certified and CHAP accredited.

Let Medical Systems

Let Medical Systems is a Hialeah, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Petaluma Health Center

Petaluma Health Center is a Petaluma, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.